LUND, Sweden, Nov. 7, 2023 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic cancer, today announced the successful completion of ...

Please provide your email address to receive an email when new articles are posted on . The next-generation Cologuard test was significantly more likely to detect cancer (94% vs. 67%) compared with ...

UNDATED (WKRC) - Researchers claim they have developed a process that can detect and identify nearly any infectious agent in a patient with just a single test. A new study from Nature Medicine ...

Nearly a decade after the original Cologuard test received premarket approval from the FDA and became a blockbuster hit as a screening tool for colorectal cancer, its maker Exact Sciences is planning ...

NF1-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of NF1-Mutant Rhabdomyosarcoma and NF1-Associated Malignant Triton Tumor The Prostate Cancer Precision Medicine Multi ...